UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Phospholipiduria in 2-bromoethanamine-induced renal papillary necrosis
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Authors:
    Thanh NTK, Obatomi DK, Bach PH
  • Publication date:
    2001
  • Pagination:
    {326-334}
  • Journal:
    BIOMARKERS
  • Volume:
    6
  • Article number:
    5
  • Print ISSN:
    1354-750X
  • Notes:
    unique-id: ISI:000170235200003
Abstract
The possibility that phospholipid excretion in urine might be a marker of renal papillary necrosis (RPN) induced by 2-bromoethanamine (BEA) was investigated in male Wistar rats following a single i.p. injection in time course and dose-response experiments. Urinary and serum creatinine as well as electrolytes were also measured in parallel to histological examination of tissues. A single i.p. injection of BEA caused a characteristic dose-related change in urinary phospholipids, notably sphingomyelin (SPM), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) excretion on the first day of treatment. At a lower dose of 30 mg kg(1) BEA, there was no alteration in the levels of the phospholipids; however, significant increases in the excretion of SPM, PC and PE at the 90 and 240 mg kg(1) dose level were observed. There was an early increase in the three phospholipids irrespective of whether the excretion is expressed in units per hour excretion or units per milligram creatinine. The increased excretion of SPM and PC remained over 4 days while PE levels returned to normal after day 1. On day 1, urinary flow rate and creatinine were also increased significantly while there was a significant fall in the levels of some electrolytes (Na+, K+, Cl). Parallel histological examination also confirmed the presence of RPN at the two higher doses (90, 240 mg kg(1)) of BEA. Other measurements such as blood urea nitrogen and the levels of Ca2+ and Mg2+ in blood were unaffected at all dose levels of BEA. These results demonstrate the potential of specific urinary phospholipids as diagnostic bio-markers for early renal injury associated with RPN and may provide an important improvement in the non-invasive approach to the therapeutic management of renal diseases, and potentially prevent further degenerative changes.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Dept of Physics & Astronomy
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by